Clinical Trial Update: Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant [NA]

View source ↗

Summary

Clinical trial on desipramine hydrochloride and filgrastim for stem cell mobilization in multiple myeloma patients undergoing stem cell transplant; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasma Cell Myeloma

Drugs mentioned

• DESIPRAMINE HYDROCHLORIDE (Desipramine hydrochloride)
• Filgrastim (filgrastim)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: DS (Durie/Salmon) Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma | NA | Status: TERMINATED | Results posted: 2023-03-28